Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass - A randomized, double-blind, controlled study of 21 obese hypertensives
R. Kuperstein et Z. Sasson, Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass - A randomized, double-blind, controlled study of 21 obese hypertensives, CIRCULATION, 102(15), 2000, pp. 1802-1806
Citations number
50
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-Glucose and insulin levels are associated with left ventricular
mass (LVM) in insulin-resistant individuals. Antihypertensive drugs have di
fferent effects on glucose and insulin metabolism (GIM) and on LVM. To eval
uate whether the effects of antihypertensive therapy on LVM are associated
with its effects on CIM, we compared the effects of atenolol and perindopri
l on these parameters in a group of insulin-resistant, obese hypertensives.
Methods and Results-A total of 21 obese, nondiabetic hypertensives who were
aged 55 +/- 12 years, had a body mass index of 32.8+/-5.0 kg/m(2), were fr
ee of coronary or valvular heart disease, and had normal LV function were r
andomized to treatment with atenolol (n=11) or perindopril (n=10). Echocard
iographic LVM corrected for height (LVM/height) and GIM (3-hour intravenous
glucose tolerance test) were measured after 4 to 6 weeks of washout and 6
months of treatment. Baseline characteristics were similar in both groups.
Atenolol and perindopril effectively reduced blood pressure (from -49+/13/9
8+/- to 127+/-8/82+/-6 mm Hg and from 148+/-9/98+/-4 to 129+/-9/82+/-6 mm H
g, respectively, for the atenolol and perindopril groups; P=0.002). Atenolo
l significantly worsened GIM parameters, fasting glucose levels (5.3+/-0.9
to 6.0+/-1.5 mmol/L: P=0.003), fasting insulin levels (121+/-131 to 189+/-2
28 pmol/L; P=0.03), and most other relevant metabolic measures (P<0.05 for
all). Perindopril did not affect GIM. Atenolol did not affect LVM/height (1
19+/-12 to 120+/-17 g/m; P=0.8), whereas perindopril significantly reduced
LVM/height (120+/-13 to 111+/-19 g/m; P=0.04).
Conclusions-In obese, hypertensive individuals, adequate and similar blood
pressure control was achieved with perindopril and atenolol. However, perin
dopril but not atenolol was associated with a more favorable GIM profile an
d led to a significant regression of LVM.